| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | mesenchyme migration | 1.65e-10 | 5 | 51 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | muscle contraction | 5.73e-06 | 400 | 51 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 5.99e-06 | 2 | 51 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | muscle system process | 6.85e-06 | 547 | 51 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM4 SCN11A CALD1 DSP ACTBL2 ACTA1 ACTA2 ACTC1 SRGAP2 TRIP10 CDC42BPB | 1.12e-05 | 912 | 51 | 11 | GO:0030029 |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 2.01e-05 | 65 | 51 | 4 | GO:0072132 | |
| GeneOntologyBiologicalProcess | filopodium assembly | 4.13e-05 | 78 | 51 | 4 | GO:0046847 | |
| GeneOntologyBiologicalProcess | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 5.97e-05 | 5 | 51 | 2 | GO:0021815 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 5.98e-05 | 720 | 51 | 9 | GO:0000226 | |
| GeneOntologyBiologicalProcess | negative regulation of filopodium assembly | 8.93e-05 | 6 | 51 | 2 | GO:0051490 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | TPM4 CALD1 DSP IFT172 ACTA1 PDE4DIP ACTC1 COLGALT2 KRT80 HSP90AB1 | 9.95e-05 | 957 | 51 | 10 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell motility involved in cerebral cortex radial glia guided migration | 1.25e-04 | 7 | 51 | 2 | GO:0021814 | |
| GeneOntologyBiologicalProcess | skeletal muscle thin filament assembly | 1.25e-04 | 7 | 51 | 2 | GO:0030240 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.74e-04 | 127 | 51 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 3.00e-04 | 372 | 51 | 6 | GO:0060485 | |
| GeneOntologyBiologicalProcess | skeletal myofibril assembly | 3.25e-04 | 11 | 51 | 2 | GO:0014866 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 5.55e-04 | 153 | 51 | 4 | GO:0030048 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM4 SLC8A3 ANK3 CALD1 DSP ACTBL2 ACTA1 PDE4DIP ACTA2 ACTC1 ACTG2 EIF3A TRIP10 KRT80 | 7.17e-07 | 1179 | 52 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM4 SLC8A3 ANK3 CALD1 DSP ACTBL2 ACTA1 PDE4DIP ACTA2 ACTC1 ACTG2 EIF3A TRIP10 KRT80 | 7.77e-07 | 1187 | 52 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM4 CALD1 ACTBL2 ACTA1 ACTA2 ACTC1 ANKRD62 ACTG2 CDC42BPB IQCG | 1.30e-06 | 576 | 52 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | lamellipodium | 1.56e-06 | 230 | 52 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.21e-06 | 290 | 52 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM4 SLC8A3 CALD1 DSP ACTBL2 ACTA1 PDE4DIP ACTC1 EIF3A TRIP10 KRT80 | 1.05e-05 | 899 | 52 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | actomyosin | 1.06e-05 | 117 | 52 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | filopodium | 1.35e-05 | 123 | 52 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | actin filament | 3.10e-05 | 146 | 52 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | myofibril | 5.78e-05 | 273 | 52 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.45e-04 | 107 | 52 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.45e-04 | 107 | 52 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.12e-04 | 118 | 52 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | cell leading edge | 2.26e-04 | 500 | 52 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | anchoring junction | 6.12e-04 | 976 | 52 | 9 | GO:0070161 | |
| GeneOntologyCellularComponent | actin-based cell projection | 6.26e-04 | 278 | 52 | 5 | GO:0098858 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 8.62e-04 | 817 | 52 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | chromocenter | 9.05e-04 | 18 | 52 | 2 | GO:0010369 | |
| GeneOntologyCellularComponent | microtubule organizing center | 1.83e-03 | 919 | 52 | 8 | GO:0005815 | |
| GeneOntologyCellularComponent | cell body | 1.96e-03 | 929 | 52 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 2.05e-03 | 27 | 52 | 2 | GO:0005865 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.36e-03 | 29 | 52 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | centrosome | 2.83e-03 | 770 | 52 | 7 | GO:0005813 | |
| GeneOntologyCellularComponent | myofilament | 2.87e-03 | 32 | 52 | 2 | GO:0036379 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 2.87e-03 | 32 | 52 | 2 | GO:0005721 | |
| GeneOntologyCellularComponent | sarcomere | 3.40e-03 | 249 | 52 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | PML body | 3.73e-03 | 125 | 52 | 3 | GO:0016605 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.07e-03 | 129 | 52 | 3 | GO:0030863 | |
| GeneOntologyCellularComponent | site of DNA damage | 4.81e-03 | 137 | 52 | 3 | GO:0090734 | |
| GeneOntologyCellularComponent | blood microparticle | 5.53e-03 | 144 | 52 | 3 | GO:0072562 | |
| GeneOntologyCellularComponent | axonal growth cone | 5.61e-03 | 45 | 52 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | nuclear body | 6.74e-03 | 903 | 52 | 7 | GO:0016604 | |
| Domain | ACTINS_1 | 6.23e-12 | 8 | 50 | 5 | PS00406 | |
| Domain | Actin_CS | 4.78e-10 | 16 | 50 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 6.76e-10 | 17 | 50 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 9.34e-10 | 18 | 50 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.27e-09 | 19 | 50 | 5 | PS01132 | |
| Domain | FCH | 2.85e-09 | 22 | 50 | 5 | PF00611 | |
| Domain | FCH | 2.85e-09 | 22 | 50 | 5 | SM00055 | |
| Domain | FCH_dom | 3.63e-09 | 23 | 50 | 5 | IPR001060 | |
| Domain | F_BAR | 5.71e-09 | 25 | 50 | 5 | IPR031160 | |
| Domain | F_BAR | 5.71e-09 | 25 | 50 | 5 | PS51741 | |
| Domain | Actin | 1.81e-08 | 31 | 50 | 5 | IPR004000 | |
| Domain | Actin | 1.81e-08 | 31 | 50 | 5 | PF00022 | |
| Domain | ACTIN | 1.81e-08 | 31 | 50 | 5 | SM00268 | |
| Domain | srGAP2 | 1.81e-08 | 3 | 50 | 3 | IPR030252 | |
| Domain | Chromodomain_CS | 1.43e-05 | 18 | 50 | 3 | IPR023779 | |
| Domain | Chromo_shadow | 2.10e-05 | 3 | 50 | 2 | PF01393 | |
| Domain | ChSh | 2.10e-05 | 3 | 50 | 2 | SM00300 | |
| Domain | Chromo_shadow_dom | 2.10e-05 | 3 | 50 | 2 | IPR008251 | |
| Domain | Chromo_domain | 3.51e-05 | 24 | 50 | 3 | IPR023780 | |
| Domain | Chromo | 4.49e-05 | 26 | 50 | 3 | PF00385 | |
| Domain | CHROMO_2 | 5.64e-05 | 28 | 50 | 3 | PS50013 | |
| Domain | CHROMO_1 | 5.64e-05 | 28 | 50 | 3 | PS00598 | |
| Domain | Chromodomain-like | 8.48e-05 | 32 | 50 | 3 | IPR016197 | |
| Domain | CHROMO | 9.31e-05 | 33 | 50 | 3 | SM00298 | |
| Domain | Chromo/shadow_dom | 9.31e-05 | 33 | 50 | 3 | IPR000953 | |
| Domain | Chromo_dom_subgr | 3.12e-04 | 10 | 50 | 2 | IPR017984 | |
| Domain | Ank_3 | 3.12e-04 | 10 | 50 | 2 | PF13606 | |
| Domain | SH3_1 | 9.63e-03 | 164 | 50 | 3 | PF00018 | |
| Domain | RhoGAP | 1.20e-02 | 62 | 50 | 2 | SM00324 | |
| Domain | RhoGAP | 1.24e-02 | 63 | 50 | 2 | PF00620 | |
| Domain | RHOGAP | 1.27e-02 | 64 | 50 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 1.27e-02 | 64 | 50 | 2 | IPR000198 | |
| Domain | - | 1.27e-02 | 64 | 50 | 2 | 1.10.555.10 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 6.76e-08 | 203 | 39 | 8 | M5485 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TPM4 BCAP31 DSP SRGAP1 ACTC1 ANKRD62 SRGAP2 TRIP10 CDC42BPB HSP90AB1 | 2.19e-07 | 439 | 39 | 10 | MM15595 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.97e-07 | 165 | 39 | 7 | MM15026 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 2.46e-06 | 35 | 39 | 4 | MM15114 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TPM4 BCAP31 DSP SRGAP1 ACTC1 SRGAP2 TRIP10 CDC42BPB HSP90AB1 | 2.87e-06 | 450 | 39 | 9 | M27078 |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 3.45e-06 | 38 | 39 | 4 | M39549 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 5.71e-06 | 43 | 39 | 4 | M1429 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TPM4 BCAP31 DSP SRGAP1 ACTC1 ANKRD62 SRGAP2 TRIP10 CDC42BPB HSP90AB1 | 7.54e-06 | 649 | 39 | 10 | MM15690 |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 8.19e-06 | 47 | 39 | 4 | M39829 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 6.61e-05 | 156 | 39 | 5 | M39475 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TPM4 BCAP31 DSP SRGAP1 ACTC1 SRGAP2 TRIP10 CDC42BPB HSP90AB1 | 1.20e-04 | 720 | 39 | 9 | M41838 |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.21e-04 | 35 | 39 | 3 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.31e-04 | 36 | 39 | 3 | M18647 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 1.43e-04 | 37 | 39 | 3 | M39756 | |
| Pathway | REACTOME_INACTIVATION_OF_CDC42_AND_RAC1 | 2.07e-04 | 8 | 39 | 2 | M27349 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 5.44e-04 | 58 | 39 | 3 | MM15602 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 5.72e-04 | 59 | 39 | 3 | M41812 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 8.37e-04 | 154 | 39 | 4 | MM15974 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.54e-03 | 83 | 39 | 3 | M8728 | |
| Pathway | REACTOME_SUMOYLATION | 1.78e-03 | 189 | 39 | 4 | M27214 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.95e-03 | 90 | 39 | 3 | M835 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 6.65e-11 | 6 | 52 | 4 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 6.65e-11 | 6 | 52 | 4 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 6.65e-11 | 6 | 52 | 4 | 11709093 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 6.65e-11 | 6 | 52 | 4 | 9971772 | |
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 10049817 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 6.65e-11 | 6 | 52 | 4 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 6.65e-11 | 6 | 52 | 4 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 6.65e-11 | 6 | 52 | 4 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 6.65e-11 | 6 | 52 | 4 | 8661406 | |
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 23017337 | ||
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 6.65e-11 | 6 | 52 | 4 | 10074138 | |
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 6.65e-11 | 6 | 52 | 4 | 23875777 | |
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 9841925 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 1.55e-10 | 7 | 52 | 4 | 17504171 | |
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 22535526 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 22465675 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 1.55e-10 | 7 | 52 | 4 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 1.55e-10 | 7 | 52 | 4 | 22640593 | |
| Pubmed | TPM4 SCN11A BCAP31 DDX17 CALD1 DSP PCDHGA12 CBX5 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CHD3 EIF3A HSP90AB1 | 1.77e-10 | 1442 | 52 | 16 | 35575683 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.55e-10 | 271 | 52 | 9 | 32433965 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM4 RBM25 BCAP31 DDX17 CALD1 DSP ACTA2 ACTC1 TSN CHD3 EIF3A HSP90AB1 HSP90AB3P | 2.56e-10 | 847 | 52 | 13 | 35235311 |
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 14694110 | ||
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 20147394 | ||
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 23260110 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 4.35e-10 | 288 | 52 | 9 | 31501420 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 5.57e-10 | 9 | 52 | 4 | 8892894 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 5.57e-10 | 9 | 52 | 4 | 10556093 | |
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 18775311 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 9.27e-10 | 10 | 52 | 4 | 1991513 | |
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 23575248 | ||
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 1907279 | ||
| Pubmed | 1.45e-09 | 11 | 52 | 4 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 1.45e-09 | 11 | 52 | 4 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 1.45e-09 | 11 | 52 | 4 | 19639585 | |
| Pubmed | 2.18e-09 | 12 | 52 | 4 | 23071112 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RBM25 DDX17 CALD1 DSP CBX5 ACTBL2 ACTA1 ACTC1 CBX1 CHD3 EIF3A KRT80 HSP90AB1 | 2.54e-09 | 1024 | 52 | 13 | 24711643 |
| Pubmed | 3.15e-09 | 3 | 52 | 3 | 22559944 | ||
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 3.15e-09 | 3 | 52 | 3 | 7780165 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 4.39e-09 | 256 | 52 | 8 | 24189400 | |
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 21923909 | ||
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 17411366 | ||
| Pubmed | 1.04e-08 | 17 | 52 | 4 | 17360745 | ||
| Pubmed | 1.04e-08 | 17 | 52 | 4 | 8997639 | ||
| Pubmed | DDX17 DSP CBX5 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CHD3 EIF3A KRT80 HSP90AB1 HSP90AB3P | 1.04e-08 | 1153 | 52 | 13 | 29845934 | |
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 1.26e-08 | 4 | 52 | 3 | 22559943 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.93e-08 | 605 | 52 | 10 | 28977666 | |
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 10615402 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 3.19e-08 | 22 | 52 | 4 | 16526095 | |
| Pubmed | 3.19e-08 | 22 | 52 | 4 | 14627618 | ||
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 3.85e-08 | 23 | 52 | 4 | 22004035 | |
| Pubmed | TPM4 DDX17 ANK3 DSP ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CHD3 HSP90AB1 | 3.93e-08 | 844 | 52 | 11 | 25963833 | |
| Pubmed | 4.37e-08 | 660 | 52 | 10 | 32780723 | ||
| Pubmed | 6.28e-08 | 6 | 52 | 3 | 12736724 | ||
| Pubmed | 6.48e-08 | 26 | 52 | 4 | 24742657 | ||
| Pubmed | 6.82e-08 | 239 | 52 | 7 | 23246001 | ||
| Pubmed | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. | 1.10e-07 | 7 | 52 | 3 | 19118250 | |
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.10e-07 | 7 | 52 | 3 | 9384381 | |
| Pubmed | 1.10e-07 | 7 | 52 | 3 | 30289203 | ||
| Pubmed | 1.27e-07 | 156 | 52 | 6 | 29961565 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM4 RBM25 DDX17 CALD1 DSP ACTA1 ACTA2 ACTC1 ACTG2 EIF3A HSP90AB1 | 1.28e-07 | 949 | 52 | 11 | 36574265 |
| Pubmed | TPM4 DDX17 ANK3 CALD1 DSP ACTBL2 ACTA1 PDE4DIP CHD3 SRGAP2 EIF3A CDC42BPB HSP90AB1 | 1.30e-07 | 1431 | 52 | 13 | 37142655 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.48e-07 | 268 | 52 | 7 | 33024031 | |
| Pubmed | 1.55e-07 | 32 | 52 | 4 | 23369715 | ||
| Pubmed | 1.76e-07 | 8 | 52 | 3 | 20096780 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 1.82e-07 | 580 | 52 | 9 | 35676659 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM4 RBM25 DDX17 DSP SRGAP1 ACTBL2 ACTC1 ITGA6 CBX1 EIF3A KRT80 HSP90AB1 | 2.55e-07 | 1257 | 52 | 12 | 36526897 |
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 2.63e-07 | 9 | 52 | 3 | 12297046 | |
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 3.75e-07 | 10 | 52 | 3 | 21749862 | |
| Pubmed | 4.14e-07 | 312 | 52 | 7 | 37120454 | ||
| Pubmed | 4.18e-07 | 191 | 52 | 6 | 33762435 | ||
| Pubmed | HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. | 4.32e-07 | 41 | 52 | 4 | 24614889 | |
| Pubmed | 5.16e-07 | 11 | 52 | 3 | 22207710 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 5.24e-07 | 477 | 52 | 8 | 31300519 | |
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 5.98e-07 | 203 | 52 | 6 | 24244333 | |
| Pubmed | 6.21e-07 | 488 | 52 | 8 | 31324722 | ||
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 6.87e-07 | 12 | 52 | 3 | 31042497 | |
| Pubmed | 7.13e-07 | 497 | 52 | 8 | 23414517 | ||
| Pubmed | 7.36e-07 | 340 | 52 | 7 | 24332808 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM4 DDX17 ANK3 CALD1 DSP ACTBL2 ACTA2 ACTC1 SRGAP2 EIF3A HSP90AB1 | 8.51e-07 | 1149 | 52 | 11 | 35446349 |
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 8.92e-07 | 13 | 52 | 3 | 18400219 | |
| Pubmed | 9.03e-07 | 513 | 52 | 8 | 25798074 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.06e-06 | 934 | 52 | 10 | 33916271 | |
| Pubmed | 1.13e-06 | 14 | 52 | 3 | 17766470 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.28e-06 | 954 | 52 | 10 | 36373674 | |
| Pubmed | 1.33e-06 | 54 | 52 | 4 | 22266860 | ||
| Pubmed | 1.42e-06 | 15 | 52 | 3 | 24598388 | ||
| Pubmed | Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. | 1.74e-06 | 16 | 52 | 3 | 16638982 | |
| Pubmed | Serum response factor is essential for mesoderm formation during mouse embryogenesis. | 1.74e-06 | 16 | 52 | 3 | 9799237 | |
| Pubmed | 1.87e-06 | 247 | 52 | 6 | 30713523 | ||
| Pubmed | Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. | 2.19e-06 | 2 | 52 | 2 | 19468071 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 17891782 | ||
| Pubmed | Heterochromatin protein 1 expression is reduced in human thyroid malignancy. | 2.19e-06 | 2 | 52 | 2 | 24840329 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 33984363 | ||
| Pubmed | Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. | 2.19e-06 | 2 | 52 | 2 | 11242054 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 20706863 | ||
| Pubmed | alpha-Actin proteins and gene transcripts are colocalized in embryonic mouse muscle. | 2.19e-06 | 2 | 52 | 2 | 1893870 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 31822692 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 27373832 | ||
| Pubmed | Heterochromatin protein 1 binds to nucleosomes and DNA in vitro. | 2.19e-06 | 2 | 52 | 2 | 10882726 | |
| Interaction | NEXN interactions | 3.43e-09 | 91 | 52 | 7 | int:NEXN | |
| Interaction | ACTG2 interactions | 1.64e-07 | 49 | 52 | 5 | int:ACTG2 | |
| Interaction | POTEJ interactions | 2.23e-07 | 52 | 52 | 5 | int:POTEJ | |
| Interaction | ACTB interactions | TPM4 TRIM15 BCAP31 CALD1 CBX5 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CHD3 SRGAP2 SMC5 HSP90AB1 | 4.00e-07 | 1083 | 52 | 14 | int:ACTB |
| Interaction | ISG15 interactions | TPM4 RBM25 BCAP31 DDX17 CALD1 CBX5 ACTBL2 ACTA1 ACTC1 HSP90AB1 | 4.49e-07 | 494 | 52 | 10 | int:ISG15 |
| Interaction | ACTG1 interactions | BCAP31 CALD1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CHD3 SMC5 HSP90AB1 | 7.17e-07 | 520 | 52 | 10 | int:ACTG1 |
| Interaction | CAP2 interactions | 7.45e-07 | 66 | 52 | 5 | int:CAP2 | |
| Interaction | CAP1 interactions | 9.85e-07 | 207 | 52 | 7 | int:CAP1 | |
| Interaction | POTEE interactions | 1.22e-06 | 134 | 52 | 6 | int:POTEE | |
| Interaction | DISC1 interactions | 1.35e-06 | 429 | 52 | 9 | int:DISC1 | |
| Interaction | PLEC interactions | 1.38e-06 | 430 | 52 | 9 | int:PLEC | |
| Interaction | TFCP2 interactions | 1.54e-06 | 436 | 52 | 9 | int:TFCP2 | |
| Interaction | ANGPTL8 interactions | 1.92e-06 | 10 | 52 | 3 | int:ANGPTL8 | |
| Interaction | PFN3 interactions | 1.92e-06 | 10 | 52 | 3 | int:PFN3 | |
| Interaction | ABRA interactions | 2.18e-06 | 36 | 52 | 4 | int:ABRA | |
| Interaction | OBSL1 interactions | RBM25 DDX17 CALD1 DSP CBX5 ACTBL2 RTTN ACTA1 ACTC1 CBX1 EIF3A HSP90AB1 | 2.37e-06 | 902 | 52 | 12 | int:OBSL1 |
| Interaction | WASH8P interactions | 2.63e-06 | 11 | 52 | 3 | int:WASH8P | |
| Interaction | AKT3 interactions | 2.64e-06 | 85 | 52 | 5 | int:AKT3 | |
| Interaction | MYH9 interactions | TPM4 BCAP31 CALD1 ACTBL2 ACTA1 ACTA2 ACTC1 CHD3 EIF3A SMC5 HSP90AB1 | 2.78e-06 | 754 | 52 | 11 | int:MYH9 |
| Interaction | HNRNPF interactions | 2.89e-06 | 607 | 52 | 10 | int:HNRNPF | |
| Interaction | ACE2 interactions | TPM4 RBM25 DDX17 CALD1 DSP CBX5 RAB3IP RTTN TSN CHD3 EIF3A KRT80 HSP90AB1 | 3.27e-06 | 1106 | 52 | 13 | int:ACE2 |
| Interaction | ADARB1 interactions | 3.94e-06 | 489 | 52 | 9 | int:ADARB1 | |
| Interaction | CALD1 interactions | 5.07e-06 | 265 | 52 | 7 | int:CALD1 | |
| Interaction | SPATA22 interactions | 5.78e-06 | 14 | 52 | 3 | int:SPATA22 | |
| Interaction | IVNS1ABP interactions | 6.76e-06 | 180 | 52 | 6 | int:IVNS1ABP | |
| Interaction | FBXO40 interactions | 7.21e-06 | 15 | 52 | 3 | int:FBXO40 | |
| Interaction | NAA80 interactions | 7.21e-06 | 15 | 52 | 3 | int:NAA80 | |
| Interaction | POTEI interactions | 7.46e-06 | 105 | 52 | 5 | int:POTEI | |
| Interaction | NUPR1 interactions | 8.17e-06 | 683 | 52 | 10 | int:NUPR1 | |
| Interaction | ERRFI1 interactions | 8.18e-06 | 107 | 52 | 5 | int:ERRFI1 | |
| Interaction | DBN1 interactions | 1.07e-05 | 417 | 52 | 8 | int:DBN1 | |
| Interaction | REG3A interactions | 1.07e-05 | 17 | 52 | 3 | int:REG3A | |
| Interaction | METTL14 interactions | 1.14e-05 | 558 | 52 | 9 | int:METTL14 | |
| Interaction | WASL interactions | 1.26e-05 | 117 | 52 | 5 | int:WASL | |
| Interaction | LIMA1 interactions | 1.31e-05 | 429 | 52 | 8 | int:LIMA1 | |
| Interaction | FGD5 interactions | 1.50e-05 | 207 | 52 | 6 | int:FGD5 | |
| Interaction | SCIN interactions | 1.51e-05 | 58 | 52 | 4 | int:SCIN | |
| Interaction | LRRC20 interactions | 1.52e-05 | 19 | 52 | 3 | int:LRRC20 | |
| Interaction | TNNI3K interactions | 1.52e-05 | 19 | 52 | 3 | int:TNNI3K | |
| Interaction | NEK4 interactions | DDX17 IFT172 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 HSP90AB1 HSP90AB3P | 1.60e-05 | 582 | 52 | 9 | int:NEK4 |
| Interaction | HEXIM1 interactions | DDX17 DSP ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CHD3 EIF3A KRT80 HSP90AB1 | 1.70e-05 | 913 | 52 | 11 | int:HEXIM1 |
| Interaction | YAP1 interactions | RBM25 DDX17 ANK3 CALD1 DSP ACTBL2 ACTA1 ACTA2 ACTC1 EIF3A HSP90AB1 HSP90AB3P | 1.70e-05 | 1095 | 52 | 12 | int:YAP1 |
| Interaction | CTTN interactions | 1.85e-05 | 450 | 52 | 8 | int:CTTN | |
| Interaction | GC interactions | 1.97e-05 | 62 | 52 | 4 | int:GC | |
| Interaction | CHD3 interactions | 1.99e-05 | 757 | 52 | 10 | int:CHD3 | |
| Interaction | BAP1 interactions | TPM4 DDX17 ANK3 CALD1 DSP CBX5 ACTBL2 ACTA2 ACTC1 CBX1 SRGAP2 EIF3A HSP90AB1 | 2.10e-05 | 1314 | 52 | 13 | int:BAP1 |
| Interaction | SMARCA4 interactions | 2.23e-05 | 462 | 52 | 8 | int:SMARCA4 | |
| Interaction | TINF2 interactions | 2.27e-05 | 132 | 52 | 5 | int:TINF2 | |
| Interaction | FNBP4 interactions | 2.84e-05 | 68 | 52 | 4 | int:FNBP4 | |
| Interaction | TRIM37 interactions | 2.98e-05 | 630 | 52 | 9 | int:TRIM37 | |
| Interaction | UBL4A interactions | 3.01e-05 | 349 | 52 | 7 | int:UBL4A | |
| Interaction | NAA40 interactions | TPM4 DDX17 CALD1 DSP ACTA1 CBX1 CHD3 SRGAP2 EIF3A SMC5 HSP90AB1 | 3.22e-05 | 978 | 52 | 11 | int:NAA40 |
| Interaction | SMARCC2 interactions | 3.24e-05 | 353 | 52 | 7 | int:SMARCC2 | |
| Interaction | ACTA2 interactions | 3.36e-05 | 355 | 52 | 7 | int:ACTA2 | |
| Interaction | GTF2I interactions | 4.59e-05 | 373 | 52 | 7 | int:GTF2I | |
| Interaction | UCHL1 interactions | 4.63e-05 | 253 | 52 | 6 | int:UCHL1 | |
| Interaction | ARAF interactions | 4.83e-05 | 376 | 52 | 7 | int:ARAF | |
| Interaction | SUV39H2 interactions | 4.88e-05 | 78 | 52 | 4 | int:SUV39H2 | |
| Interaction | CUL7 interactions | 5.08e-05 | 845 | 52 | 10 | int:CUL7 | |
| Interaction | PINK1 interactions | 5.33e-05 | 679 | 52 | 9 | int:PINK1 | |
| Interaction | TMSB4X interactions | 5.39e-05 | 80 | 52 | 4 | int:TMSB4X | |
| Interaction | CFL1 interactions | 5.52e-05 | 384 | 52 | 7 | int:CFL1 | |
| Interaction | NPB interactions | 5.65e-05 | 29 | 52 | 3 | int:NPB | |
| Interaction | PHACTR2 interactions | 5.65e-05 | 29 | 52 | 3 | int:PHACTR2 | |
| Interaction | YLPM1 interactions | 5.70e-05 | 160 | 52 | 5 | int:YLPM1 | |
| Interaction | MEPCE interactions | RBM25 DDX17 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 EIF3A KRT80 HSP90AB1 | 5.83e-05 | 859 | 52 | 10 | int:MEPCE |
| Interaction | CIT interactions | TPM4 ANKRD35 RBM25 DDX17 DSP CBX5 ACTC1 CBX1 CHD3 EIF3A HERC1 HSP90AB1 HSP90AB3P | 5.88e-05 | 1450 | 52 | 13 | int:CIT |
| Interaction | KIF20A interactions | TPM4 ANKRD35 RBM25 DDX17 DSP CBX5 ACTC1 EIF3A HERC1 CDC42BPB HSP90AB1 | 6.25e-05 | 1052 | 52 | 11 | int:KIF20A |
| Interaction | ACTC1 interactions | 6.31e-05 | 694 | 52 | 9 | int:ACTC1 | |
| Interaction | MCM2 interactions | TPM4 DDX17 ANK3 DSP ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CHD3 HSP90AB1 | 7.98e-05 | 1081 | 52 | 11 | int:MCM2 |
| Interaction | PRKCE interactions | 8.25e-05 | 173 | 52 | 5 | int:PRKCE | |
| Interaction | DDX39B interactions | 9.80e-05 | 570 | 52 | 8 | int:DDX39B | |
| Interaction | NUDCD2 interactions | 1.03e-04 | 424 | 52 | 7 | int:NUDCD2 | |
| Interaction | LARP7 interactions | DDX17 DSP CBX5 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 EIF3A HSP90AB1 HSP90AB3P | 1.04e-04 | 1113 | 52 | 11 | int:LARP7 |
| Interaction | DUSP19 interactions | 1.10e-04 | 96 | 52 | 4 | int:DUSP19 | |
| Interaction | TRAF3IP1 interactions | 1.10e-04 | 96 | 52 | 4 | int:TRAF3IP1 | |
| Interaction | ACTBL2 interactions | 1.10e-04 | 296 | 52 | 6 | int:ACTBL2 | |
| Interaction | EPB41L2 interactions | 1.16e-04 | 299 | 52 | 6 | int:EPB41L2 | |
| Interaction | PYGM interactions | 1.19e-04 | 98 | 52 | 4 | int:PYGM | |
| Interaction | ACIN1 interactions | 1.21e-04 | 301 | 52 | 6 | int:ACIN1 | |
| Interaction | CHD4 interactions | 1.21e-04 | 938 | 52 | 10 | int:CHD4 | |
| Interaction | LBR interactions | 1.27e-04 | 304 | 52 | 6 | int:LBR | |
| Interaction | VMP1 interactions | 1.28e-04 | 190 | 52 | 5 | int:VMP1 | |
| Interaction | PHF14 interactions | 1.29e-04 | 100 | 52 | 4 | int:PHF14 | |
| Interaction | DNASE1 interactions | 1.36e-04 | 7 | 52 | 2 | int:DNASE1 | |
| Interaction | NME1 interactions | 1.38e-04 | 193 | 52 | 5 | int:NME1 | |
| Interaction | H2BC9 interactions | 1.40e-04 | 446 | 52 | 7 | int:H2BC9 | |
| Interaction | ADNP interactions | 1.59e-04 | 199 | 52 | 5 | int:ADNP | |
| Interaction | LRCH3 interactions | 1.73e-04 | 108 | 52 | 4 | int:LRCH3 | |
| Interaction | KCTD13 interactions | TPM4 DDX17 ANK3 CALD1 DSP ACTBL2 ACTA1 CHD3 SRGAP2 EIF3A CDC42BPB HSP90AB1 | 1.77e-04 | 1394 | 52 | 12 | int:KCTD13 |
| Interaction | NLRC3 interactions | 1.81e-04 | 8 | 52 | 2 | int:NLRC3 | |
| Interaction | ORC2 interactions | 1.86e-04 | 110 | 52 | 4 | int:ORC2 | |
| Interaction | VIM interactions | 1.93e-04 | 804 | 52 | 9 | int:VIM | |
| Interaction | SF3A1 interactions | 1.96e-04 | 471 | 52 | 7 | int:SF3A1 | |
| Interaction | LNX1 interactions | 2.03e-04 | 634 | 52 | 8 | int:LNX1 | |
| Interaction | SMC5 interactions | 2.04e-04 | 1000 | 52 | 10 | int:SMC5 | |
| Interaction | BRD7 interactions | 2.10e-04 | 637 | 52 | 8 | int:BRD7 | |
| Interaction | TNIP1 interactions | TPM4 RBM25 DDX17 CALD1 DSP ACTA1 ACTA2 ACTC1 ACTG2 EIF3A HSP90AB1 | 2.27e-04 | 1217 | 52 | 11 | int:TNIP1 |
| Interaction | ACTR1B interactions | 2.28e-04 | 116 | 52 | 4 | int:ACTR1B | |
| Interaction | RNF217 interactions | 2.32e-04 | 9 | 52 | 2 | int:RNF217 | |
| GeneFamily | Actins | 2.22e-10 | 6 | 37 | 4 | 929 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 8.88e-10 | 23 | 37 | 5 | 1288 | |
| GeneFamily | Chromobox family | 1.13e-04 | 8 | 37 | 2 | 976 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.69e-03 | 50 | 37 | 2 | 721 | |
| GeneFamily | Ankyrin repeat domain containing | 1.32e-02 | 242 | 37 | 3 | 403 | |
| Coexpression | TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL | 6.61e-06 | 61 | 52 | 4 | M41672 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.79e-05 | 163 | 52 | 5 | M2769 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN | 2.88e-05 | 30 | 52 | 3 | M3034 | |
| Coexpression | AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4 | 3.21e-05 | 184 | 52 | 5 | M39135 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 3.22e-05 | 458 | 52 | 7 | M40010 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN | 3.51e-05 | 32 | 52 | 3 | MM472 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 3.74e-05 | 316 | 52 | 6 | M2293 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 3.74e-05 | 316 | 52 | 6 | M2248 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 4.01e-05 | 320 | 52 | 6 | MM1063 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 4.22e-05 | 323 | 52 | 6 | MM1066 | |
| Coexpression | GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP | 4.78e-05 | 200 | 52 | 5 | M4344 | |
| Coexpression | ZHANG_UTERUS_C11_SMOOTH_MUSCLE_CELL | 5.02e-05 | 36 | 52 | 3 | MM16617 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 6.30e-05 | 212 | 52 | 5 | M39221 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | 6.44e-05 | 213 | 52 | 5 | M14601 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 8.05e-05 | 363 | 52 | 6 | M41103 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | 8.61e-05 | 939 | 52 | 9 | M45768 | |
| Coexpression | MELLMAN_TUT1_TARGETS_DN | 1.12e-04 | 47 | 52 | 3 | M16335 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.15e-04 | 126 | 52 | 4 | M39132 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 1.20e-04 | 48 | 52 | 3 | M1568 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 1.27e-04 | 49 | 52 | 3 | MM1178 | |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN | 1.98e-04 | 145 | 52 | 4 | M11513 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 2.38e-04 | 843 | 52 | 8 | M2356 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | 3.17e-04 | 662 | 52 | 7 | M8124 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | 3.42e-04 | 1129 | 52 | 9 | M42508 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 3.79e-04 | 172 | 52 | 4 | M1134 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | 4.12e-04 | 1158 | 52 | 9 | MM1338 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 4.99e-04 | 185 | 52 | 4 | M1137 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 5.09e-04 | 186 | 52 | 4 | M1140 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 5.09e-04 | 186 | 52 | 4 | MM498 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN | 5.24e-04 | 79 | 52 | 3 | M19636 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_SMOOTH_MUSCLE_CELLS | 5.63e-04 | 81 | 52 | 3 | M40258 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 5.63e-04 | 81 | 52 | 3 | M39253 | |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP | 5.70e-04 | 341 | 52 | 5 | M12636 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN | 5.74e-04 | 192 | 52 | 4 | M4703 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP | 5.85e-04 | 193 | 52 | 4 | M9233 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.97e-04 | 194 | 52 | 4 | M39122 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | 6.19e-04 | 973 | 52 | 8 | M41080 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 6.20e-04 | 196 | 52 | 4 | M7664 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP | 6.44e-04 | 198 | 52 | 4 | M5152 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN | 6.44e-04 | 198 | 52 | 4 | M4443 | |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 6.49e-04 | 85 | 52 | 3 | M12924 | |
| Coexpression | GSE3039_B2_VS_B1_BCELL_UP | 6.56e-04 | 199 | 52 | 4 | M6450 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 6.56e-04 | 199 | 52 | 4 | M5284 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN | 6.56e-04 | 199 | 52 | 4 | M8313 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 6.56e-04 | 199 | 52 | 4 | M9031 | |
| Coexpression | GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN | 6.56e-04 | 199 | 52 | 4 | M4243 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN | 6.56e-04 | 199 | 52 | 4 | M4997 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 6.69e-04 | 200 | 52 | 4 | M5030 | |
| Coexpression | GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN | 6.69e-04 | 200 | 52 | 4 | M4656 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 6.69e-04 | 200 | 52 | 4 | M8306 | |
| Coexpression | GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN | 6.69e-04 | 200 | 52 | 4 | M8325 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 6.69e-04 | 200 | 52 | 4 | M9563 | |
| Coexpression | GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN | 6.69e-04 | 200 | 52 | 4 | M9552 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN | 6.69e-04 | 200 | 52 | 4 | M8612 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 6.69e-04 | 200 | 52 | 4 | M8610 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP | 6.69e-04 | 200 | 52 | 4 | M9900 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP | 6.69e-04 | 200 | 52 | 4 | M9903 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP | 6.69e-04 | 200 | 52 | 4 | M7501 | |
| Coexpression | GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.69e-04 | 200 | 52 | 4 | M9161 | |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_DN | 6.71e-04 | 86 | 52 | 3 | M17143 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 6.81e-04 | 201 | 52 | 4 | MM500 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 6.81e-04 | 201 | 52 | 4 | MM502 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN | 6.94e-04 | 87 | 52 | 3 | MM992 | |
| Coexpression | MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN | 7.17e-04 | 20 | 52 | 2 | M1991 | |
| Coexpression | JONES_OVARY_NK_CELL | 7.42e-04 | 89 | 52 | 3 | M48353 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 7.47e-04 | 206 | 52 | 4 | M39254 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 7.66e-04 | 90 | 52 | 3 | M39250 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | 8.28e-04 | 1276 | 52 | 9 | M39173 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS | 8.43e-04 | 93 | 52 | 3 | M39279 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 4.24e-07 | 26 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 5.79e-07 | 28 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_1000 | GIMAP4 RBM25 AFAP1L2 DSP CBX5 RAB3IP ACTA2 ITGA6 CBX1 EIF3A HERC1 | 1.50e-06 | 761 | 51 | 11 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_500 | 5.31e-06 | 48 | 51 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_500 | 5.78e-06 | 107 | 51 | 5 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100 | 5.82e-06 | 15 | 51 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200 | 6.26e-06 | 50 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_500 | 8.22e-06 | 115 | 51 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_200 | 8.67e-06 | 17 | 51 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100 | 1.23e-05 | 19 | 51 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | CALD1 DSP ACTA1 PDE4DIP ACTA2 ACTC1 ACTG2 TMC4 EIF3A HSP90AB1 | 1.29e-05 | 774 | 51 | 10 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.44e-05 | 129 | 51 | 5 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 1.83e-05 | 806 | 51 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200 | 2.27e-05 | 69 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 2.27e-05 | 69 | 51 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 3.51e-05 | 77 | 51 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_200 | 3.67e-05 | 27 | 51 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_200 | 4.05e-05 | 160 | 51 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_200_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_100 | 4.72e-05 | 83 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_100_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_500 | 5.42e-05 | 86 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 5.42e-05 | 86 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_200 | 5.60e-05 | 31 | 51 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100 | 5.93e-05 | 88 | 51 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_100 | 6.16e-05 | 32 | 51 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.20e-05 | 89 | 51 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.06e-05 | 92 | 51 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.57e-05 | 37 | 51 | 3 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_200 | 1.12e-04 | 39 | 51 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_500 | 1.14e-04 | 104 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_500 | 1.62e-04 | 114 | 51 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 1.68e-04 | 115 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_500 | 1.96e-04 | 47 | 51 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_100 | 2.01e-04 | 9 | 51 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.88e-04 | 243 | 51 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 3.05e-04 | 384 | 51 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.19e-04 | 136 | 51 | 4 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 3.22e-04 | 388 | 51 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.34e-04 | 251 | 51 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 3.94e-04 | 403 | 51 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.15e-04 | 407 | 51 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_100 | 4.34e-04 | 13 | 51 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.62e-04 | 150 | 51 | 4 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.67e-04 | 270 | 51 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.35e-04 | 156 | 51 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 5.79e-04 | 797 | 51 | 8 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_200 | 5.86e-04 | 68 | 51 | 3 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_200 | 6.03e-04 | 161 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_200_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 6.24e-04 | 806 | 51 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 6.46e-04 | 164 | 51 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 7.21e-04 | 73 | 51 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 7.21e-04 | 73 | 51 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 7.54e-04 | 456 | 51 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | BM Top 100 - vagina | 8.11e-04 | 76 | 51 | 3 | BM Top 100 - vagina | |
| CoexpressionAtlas | BM Top 100 - urethra | 8.42e-04 | 77 | 51 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_100 | 8.44e-04 | 18 | 51 | 2 | gudmap_developingKidney_e15.5_Podocyte cells_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_100 | 9.08e-04 | 79 | 51 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_100 | 9.08e-04 | 79 | 51 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_100 | 9.41e-04 | 80 | 51 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_200 | 9.42e-04 | 19 | 51 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_100 | 9.42e-04 | 19 | 51 | 2 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.92e-04 | 184 | 51 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.92e-04 | 184 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_500 | 1.05e-03 | 187 | 51 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k5 | |
| CoexpressionAtlas | BM Top 100 - esophagus | 1.16e-03 | 86 | 51 | 3 | BM Top 100 - esophagus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#2_top-relative-expression-ranked_500 | 1.16e-03 | 86 | 51 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.16e-03 | 192 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k1 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_100 | 1.20e-03 | 87 | 51 | 3 | gudmap_kidney_P0_JuxtaGlom_Ren1_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_200 | 1.24e-03 | 88 | 51 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k3 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 1.25e-03 | 336 | 51 | 5 | GSM538413_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200 | 1.27e-03 | 22 | 51 | 2 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k1_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 1.32e-03 | 905 | 51 | 8 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_200 | 1.39e-03 | 23 | 51 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_200 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 1.51e-03 | 206 | 51 | 4 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.55e-03 | 95 | 51 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_1000 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 1.62e-03 | 210 | 51 | 4 | GSM403995_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.69e-03 | 98 | 51 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.69e-03 | 98 | 51 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | 1.77e-03 | 734 | 51 | 7 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.00e-03 | 104 | 51 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k4 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 2.04e-03 | 224 | 51 | 4 | GSM403994_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 2.09e-03 | 378 | 51 | 5 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 2.17e-03 | 761 | 51 | 7 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.17e-03 | 107 | 51 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_200 | 2.20e-03 | 29 | 51 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k3 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_100 | 2.20e-03 | 29 | 51 | 2 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.21e-03 | 229 | 51 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_500 | 2.26e-03 | 385 | 51 | 5 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_500 | |
| ToppCell | 18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.53e-09 | 191 | 52 | 7 | 86ce98d2c90c196474b06869de888cf5d1eed196 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-08 | 177 | 52 | 6 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-08 | 178 | 52 | 6 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.27e-08 | 183 | 52 | 6 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-08 | 183 | 52 | 6 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-08 | 183 | 52 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-08 | 185 | 52 | 6 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-08 | 185 | 52 | 6 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-08 | 185 | 52 | 6 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-08 | 191 | 52 | 6 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-08 | 191 | 52 | 6 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.66e-08 | 192 | 52 | 6 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.96e-08 | 193 | 52 | 6 | 800b0f5705fefcd3608e37801afae8a94474723e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.06e-07 | 195 | 52 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.19e-07 | 199 | 52 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-GW_trimst-1|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-07 | 199 | 52 | 6 | ecfb6381e2971a3e355e661a6df0021914485e74 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-07 | 200 | 52 | 6 | 2bc7f462a551292de2501028164573935232f899 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-07 | 200 | 52 | 6 | 8b80a65b69b36ed405214564b939452c90aa40d6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 173 | 52 | 5 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 173 | 52 | 5 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-06 | 178 | 52 | 5 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-06 | 179 | 52 | 5 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-06 | 181 | 52 | 5 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.22e-06 | 181 | 52 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-06 | 181 | 52 | 5 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-06 | 182 | 52 | 5 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 183 | 52 | 5 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 183 | 52 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 183 | 52 | 5 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.41e-06 | 184 | 52 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 184 | 52 | 5 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.68e-06 | 188 | 52 | 5 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.75e-06 | 189 | 52 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.75e-06 | 189 | 52 | 5 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | Fibroblast-D_(Pericyte)|World / shred on cell class and cell subclass (v4) | 2.97e-06 | 192 | 52 | 5 | 8c13c351fcc3d88e8c2ffa017e71ff6272cc6fac | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-06 | 193 | 52 | 5 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-06 | 193 | 52 | 5 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 3.04e-06 | 193 | 52 | 5 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-06 | 193 | 52 | 5 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-06 | 193 | 52 | 5 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-06 | 193 | 52 | 5 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-06 | 194 | 52 | 5 | 6a4e7f1bf67bad94cd8c472e7c66798b0c25ba01 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.12e-06 | 194 | 52 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 3.12e-06 | 194 | 52 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-06 | 195 | 52 | 5 | 6e875c83f838241b5fcaf4a3249b1408d74521dc | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.20e-06 | 195 | 52 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.20e-06 | 195 | 52 | 5 | 2f2e29089a8cb748d2c1329c5c8465165b25bc8b | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.20e-06 | 195 | 52 | 5 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.20e-06 | 195 | 52 | 5 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.20e-06 | 195 | 52 | 5 | c9469e2d31beb30ebb64b3f0a5239e23119fbaa5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-06 | 195 | 52 | 5 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 3.28e-06 | 196 | 52 | 5 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.28e-06 | 196 | 52 | 5 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.28e-06 | 196 | 52 | 5 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.28e-06 | 196 | 52 | 5 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-06 | 196 | 52 | 5 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.28e-06 | 196 | 52 | 5 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-06 | 196 | 52 | 5 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.36e-06 | 197 | 52 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 197 | 52 | 5 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 3.36e-06 | 197 | 52 | 5 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 197 | 52 | 5 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.36e-06 | 197 | 52 | 5 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.36e-06 | 197 | 52 | 5 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 197 | 52 | 5 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-06 | 197 | 52 | 5 | e132f4b9deef6a565262c0aa0863cafe28f248e6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 197 | 52 | 5 | 31bc9fd679d78550541d4158568e8dd09ff29e8e | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 3.45e-06 | 198 | 52 | 5 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.45e-06 | 198 | 52 | 5 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-06 | 198 | 52 | 5 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Severe_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 3.45e-06 | 198 | 52 | 5 | 09fd456077bb3a657ad3b10c6cfe799b7266456a | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.45e-06 | 198 | 52 | 5 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-06 | 198 | 52 | 5 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.45e-06 | 198 | 52 | 5 | 687f69c16343227854c882b4a0f3930ce534a3d2 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-06 | 198 | 52 | 5 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | 18-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.53e-06 | 199 | 52 | 5 | 9dd130c041beaa319727f9d22b3f45ba0da49487 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 199 | 52 | 5 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 2.16e-05 | 140 | 52 | 4 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 152 | 52 | 4 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 152 | 52 | 4 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | Monocytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.23e-05 | 155 | 52 | 4 | 82abfcee23ba08a1eb4208d367393285026e5388 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.31e-05 | 156 | 52 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-05 | 160 | 52 | 4 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.65e-05 | 160 | 52 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-05 | 160 | 52 | 4 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.74e-05 | 161 | 52 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-05 | 161 | 52 | 4 | 8aade4da418d280fec393a3032cc163909408a69 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.93e-05 | 163 | 52 | 4 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-05 | 166 | 52 | 4 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-05 | 166 | 52 | 4 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass | 4.21e-05 | 166 | 52 | 4 | 0da2c6ea1e62f1aafabafbbfbbcc6f7011739346 | |
| Computational | Muscle genes. | 8.08e-08 | 37 | 33 | 5 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 3.44e-07 | 49 | 33 | 5 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 4.22e-07 | 51 | 33 | 5 | MODULE_329 | |
| Computational | Genes in the cancer module 330. | 8.20e-05 | 28 | 33 | 3 | MODULE_330 | |
| Computational | Genes in the cancer module 201. | 4.68e-04 | 50 | 33 | 3 | MODULE_201 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.68e-04 | 50 | 33 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Drug | NpCaM | 1.09e-11 | 48 | 50 | 7 | CID000122259 | |
| Drug | AC1L1HS4 | 7.13e-11 | 32 | 50 | 6 | CID000004267 | |
| Drug | N,N'-p-phenylenedimaleimide | 1.06e-10 | 34 | 50 | 6 | CID000076765 | |
| Drug | Nsc687160 | 3.49e-10 | 18 | 50 | 5 | CID005459290 | |
| Drug | tolytoxin | 4.72e-10 | 19 | 50 | 5 | CID006440827 | |
| Drug | plakin | 5.33e-10 | 82 | 50 | 7 | CID000018752 | |
| Drug | AC1L8NVR | 8.24e-10 | 21 | 50 | 5 | CID000384633 | |
| Drug | NSC312786 | 8.24e-10 | 21 | 50 | 5 | CID000329495 | |
| Drug | azaspiracid | 5.69e-09 | 30 | 50 | 5 | CID006451158 | |
| Drug | 5-IAF | 6.76e-09 | 66 | 50 | 6 | CID000123822 | |
| Drug | Pb m | 6.97e-09 | 118 | 50 | 7 | CID006327255 | |
| Drug | AC1L1ERT | 8.88e-09 | 69 | 50 | 6 | CID000002920 | |
| Drug | caged ATP | 9.69e-09 | 70 | 50 | 6 | CID000123806 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 1.10e-08 | 34 | 50 | 5 | CID000001312 | |
| Drug | pyrene | 1.44e-08 | 131 | 50 | 7 | CID000031423 | |
| Drug | AC1NSKFN | 1.49e-08 | 36 | 50 | 5 | CID005311324 | |
| Drug | AC1NRBPQ | 1.97e-08 | 137 | 50 | 7 | CID005288569 | |
| Drug | epsilon-ATP | 2.94e-08 | 41 | 50 | 5 | CID000162262 | |
| Drug | AC1L8FNU | 4.23e-08 | 44 | 50 | 5 | CID000425429 | |
| Drug | C18:1n-7 | 5.08e-08 | 92 | 50 | 6 | CID000122325 | |
| Drug | AC1Q6LQU | 6.63e-08 | 48 | 50 | 5 | CID000072380 | |
| Drug | m2-19 | 7.78e-08 | 19 | 50 | 4 | CID000079129 | |
| Drug | beryllium fluoride | 1.00e-07 | 103 | 50 | 6 | CID000024589 | |
| Drug | 3-methylhistidine | 1.33e-07 | 55 | 50 | 5 | CID000064969 | |
| Drug | dihydrocytochalasin B | 1.75e-07 | 58 | 50 | 5 | CID000003064 | |
| Drug | oryzalin | 2.66e-07 | 63 | 50 | 5 | CID000029393 | |
| Drug | methenamine silver | 2.73e-07 | 201 | 50 | 7 | CID000004101 | |
| Drug | AC1LADJ6 | 3.99e-07 | 130 | 50 | 6 | CID000486032 | |
| Drug | CID5288653 | 4.05e-07 | 28 | 50 | 4 | CID005288653 | |
| Drug | AC1MNW2N | 4.52e-07 | 70 | 50 | 5 | CID003359490 | |
| Drug | AC1LD8HW | 6.39e-07 | 75 | 50 | 5 | CID000644061 | |
| Drug | fluorescein isothiocyanate | 8.22e-07 | 147 | 50 | 6 | CID000018730 | |
| Drug | ML-9 | 8.22e-07 | 147 | 50 | 6 | CID000004217 | |
| Drug | AC1L9EF8 | 8.29e-07 | 79 | 50 | 5 | CID000443315 | |
| Drug | carbodiimide | 9.62e-07 | 151 | 50 | 6 | CID000009864 | |
| Drug | formamide | 1.20e-06 | 85 | 50 | 5 | CID000000713 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 1.27e-06 | 86 | 50 | 5 | CID000000805 | |
| Drug | AC1NRCMD | 1.59e-06 | 90 | 50 | 5 | CID005289074 | |
| Drug | AC1L22RD | 1.68e-06 | 91 | 50 | 5 | CID000065183 | |
| Drug | cnicin | 1.77e-06 | 92 | 50 | 5 | CID000091176 | |
| Drug | mDia | 1.87e-06 | 93 | 50 | 5 | CID000128346 | |
| Drug | AC1L1GXW | 1.97e-06 | 94 | 50 | 5 | CID000003891 | |
| Drug | manidipine | 2.08e-06 | 95 | 50 | 5 | CID000004008 | |
| Drug | NSC3096 | 2.42e-06 | 98 | 50 | 5 | CID000002832 | |
| Drug | NSC106399 | 4.77e-06 | 51 | 50 | 4 | CID000002887 | |
| Drug | HU-211 | 5.10e-06 | 114 | 50 | 5 | CID000107778 | |
| Drug | blebbistatin | 5.55e-06 | 116 | 50 | 5 | CID003476986 | |
| Drug | B0683 | 5.79e-06 | 117 | 50 | 5 | CID006398969 | |
| Drug | TCNB | 6.29e-06 | 119 | 50 | 5 | CID000008330 | |
| Drug | AC1L1KMJ | 8.55e-06 | 476 | 50 | 8 | CID000030956 | |
| Drug | nocodazole | 8.68e-06 | 477 | 50 | 8 | CID000004122 | |
| Drug | microcystin-LR | 9.33e-06 | 129 | 50 | 5 | CID000445433 | |
| Drug | auxin | 9.39e-06 | 224 | 50 | 6 | CID000000801 | |
| Drug | 5'IATR | 9.42e-06 | 19 | 50 | 3 | CID000074997 | |
| Drug | NSC613009 | 9.69e-06 | 130 | 50 | 5 | CID000003800 | |
| Drug | MgCl2 | 1.16e-05 | 354 | 50 | 7 | CID000024584 | |
| Drug | Mgamp-pnp | 1.29e-05 | 21 | 50 | 3 | CID005311323 | |
| Drug | NSC60597 | 1.39e-05 | 140 | 50 | 5 | CID000003327 | |
| Drug | 0-to | 1.44e-05 | 141 | 50 | 5 | CID000002051 | |
| Drug | DE gel | 1.54e-05 | 143 | 50 | 5 | CID000008146 | |
| Drug | candesartan cilexetil | 1.64e-05 | 145 | 50 | 5 | CID000002540 | |
| Drug | dihydrosphingosine | 1.70e-05 | 146 | 50 | 5 | CID000003126 | |
| Drug | NSC339663 | 1.75e-05 | 250 | 50 | 6 | CID000003892 | |
| Drug | NSC 523214 | 1.76e-05 | 147 | 50 | 5 | CID000004752 | |
| Drug | fasudil | 2.00e-05 | 151 | 50 | 5 | CID000003547 | |
| Drug | L-Carnosine | 2.00e-05 | 73 | 50 | 4 | CID000009369 | |
| Drug | NSC717865 | 2.07e-05 | 387 | 50 | 7 | CID000005372 | |
| Drug | C3H2N2O3S | 2.11e-05 | 74 | 50 | 4 | CID000448652 | |
| Drug | DFMO | 2.27e-05 | 155 | 50 | 5 | CID000003009 | |
| Drug | CaCl2 | 2.34e-05 | 156 | 50 | 5 | CID000024854 | |
| Drug | SIRIUS | 2.47e-05 | 77 | 50 | 4 | CID000091750 | |
| Drug | ATP betaS | 2.80e-05 | 162 | 50 | 5 | CID005311341 | |
| Drug | K-Cl | 3.01e-05 | 567 | 50 | 8 | CID000004873 | |
| Drug | AC1L1BDQ | 3.84e-05 | 173 | 50 | 5 | CID000001394 | |
| Drug | phosphatidate | 4.17e-05 | 432 | 50 | 7 | CID005460104 | |
| Drug | AC1L1G9T | 4.23e-05 | 433 | 50 | 7 | CID000003591 | |
| Drug | polyproline | 4.43e-05 | 295 | 50 | 6 | CID000439587 | |
| Drug | Aspidium | 5.15e-05 | 184 | 50 | 5 | CID000000815 | |
| Drug | pentoxifylline | 5.23e-05 | 304 | 50 | 6 | CID000004740 | |
| Drug | NSC107658 | 5.42e-05 | 306 | 50 | 6 | CID000002919 | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 5.70e-05 | 188 | 50 | 5 | 595_DN | |
| Drug | MAPS | 6.15e-05 | 191 | 50 | 5 | CID000066161 | |
| Drug | AC1L1CWO | 6.21e-05 | 35 | 50 | 3 | CID000002095 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 6.26e-05 | 314 | 50 | 6 | CID000003542 | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A | 6.46e-05 | 193 | 50 | 5 | 1988_UP | |
| Drug | Rp-cAMPS | 6.62e-05 | 194 | 50 | 5 | CID006426631 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.62e-05 | 194 | 50 | 5 | 1001_UP | |
| Drug | NSC3260 | 6.78e-05 | 195 | 50 | 5 | CID000220461 | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 6.78e-05 | 195 | 50 | 5 | 2104_UP | |
| Drug | retinoic acid; Down 200; 1uM; HL60; HG-U133A | 6.95e-05 | 196 | 50 | 5 | 390_DN | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HG-U133A | 7.12e-05 | 197 | 50 | 5 | 1887_UP | |
| Drug | chlorpromazine | 7.12e-05 | 197 | 50 | 5 | CID000002726 | |
| Drug | sulphoxide | 7.18e-05 | 101 | 50 | 4 | CID000008442 | |
| Drug | etheno-NAD | 8.05e-05 | 104 | 50 | 4 | CID005288160 | |
| Drug | AC1OAGGW | 8.20e-05 | 203 | 50 | 5 | CID006857364 | |
| Drug | nitroglycerin | 8.79e-05 | 206 | 50 | 5 | CID000004510 | |
| Drug | lead nitrate | 8.99e-05 | 207 | 50 | 5 | ctd:C017461 | |
| Drug | bumetanide | 9.41e-05 | 209 | 50 | 5 | CID000002471 | |
| Drug | Ro-1724 | 1.00e-04 | 110 | 50 | 4 | CID000005087 | |
| Drug | AC1LCVPZ | 1.00e-04 | 110 | 50 | 4 | CID000656926 | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 5.71e-13 | 8 | 49 | 5 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 5.71e-13 | 8 | 49 | 5 | DOID:0081112 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 5.71e-13 | 8 | 49 | 5 | DOID:13099 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 5.71e-13 | 8 | 49 | 5 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 2.56e-12 | 10 | 49 | 5 | DOID:13832 (implicated_via_orthology) | |
| Disease | Hypertrophic Cardiomyopathy | 1.18e-04 | 57 | 49 | 3 | C0007194 | |
| Disease | Hamman-Rich syndrome | 2.43e-04 | 14 | 49 | 2 | C0085786 | |
| Disease | Usual Interstitial Pneumonia | 4.54e-04 | 19 | 49 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.54e-04 | 19 | 49 | 2 | C4721508 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 5.04e-04 | 20 | 49 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 5.56e-04 | 21 | 49 | 2 | C1800706 | |
| Disease | cancer (implicated_via_orthology) | 1.02e-03 | 268 | 49 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.07e-03 | 29 | 49 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | platelet component distribution width | 1.51e-03 | 755 | 49 | 6 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YIEVDKVTEREKVTV | 931 | Q13523 | |
| DEEEYVVEKVLDRRV | 16 | P45973 | |
| AEREIVRDIKEKLCY | 206 | P68133 | |
| EREIVRDVKEKLCYV | 206 | Q562R1 | |
| LKEREEKVREEYEEI | 156 | Q53H80 | |
| AEREIVRDIKEKLCY | 206 | P62736 | |
| TEAEVKRYTEEKERL | 661 | Q8N4X5 | |
| YEKEKEEREVVRRQL | 846 | A6NC57 | |
| EREIVRDIKEKLCYV | 206 | P63267 | |
| KYEEERRKVVRLEQE | 301 | Q8N283 | |
| QYDIEITRIKIELEE | 586 | Q49A88 | |
| KERAESVEREIQYVK | 251 | Q9Y2D1 | |
| IREYEQVIIEDRIEK | 366 | Q9H095 | |
| KTREYEKEAEREEER | 471 | P49756 | |
| VLEVREKGYERLKEE | 166 | Q96QF0 | |
| EDKVKIYGVEVEVRD | 111 | O60330 | |
| ERYIVISKVDEEERK | 236 | O95453 | |
| EYLEERRVKEVVKKH | 191 | P08238 | |
| EDQTEYLEERRVKEV | 166 | Q58FF7 | |
| EVLKKVVRYREVDEQ | 4736 | Q15751 | |
| LEKVEEFRIRYEDEI | 161 | Q6KB66 | |
| AVREIRKYDDVTEKV | 66 | P51572 | |
| VRIRKEEREIKDEKY | 1096 | P23229 | |
| EKKVLFYEEELVRRE | 691 | Q9Y5S2 | |
| EVEEVKILGKERYLV | 356 | Q9UG01 | |
| LREYQERVKKLEEVE | 841 | Q14152 | |
| EEAVKRTRDELIEYI | 386 | Q7Z6B0 | |
| YVVREEDKIEEIERE | 1291 | Q12873 | |
| YEIEDEKRRRKSVED | 1116 | P15924 | |
| EEEEEYVVEKVLDRR | 16 | P83916 | |
| LIYEDRVDRTVKEAE | 2571 | Q12955 | |
| DELYITKRRLKEIEE | 581 | Q8NEL9 | |
| PYEVDELRRKKEITV | 146 | Q92841 | |
| RTLYEQEIEVKIVEA | 361 | Q8IYK4 | |
| RRELVIKLETVEKVY | 821 | Q86VV8 | |
| KEIIAEYESQVKEIR | 11 | Q7Z6B7 | |
| VELEREKARIREEYE | 246 | Q9NUV9 | |
| REEYEEKIRKLEDKV | 256 | Q9NUV9 | |
| KEIIAEYDTQVKEIR | 11 | P0DJJ0 | |
| KEIIAEYDTQVKEIR | 11 | P0DMP2 | |
| AEREIVRDIKEKLCY | 206 | P68032 | |
| RQERYEIEETETVTK | 156 | Q05682 | |
| DRYVKFVKERTEVEQ | 26 | Q15642 | |
| IYDEETKRRLRKEDE | 1306 | Q8N2C7 | |
| EADRKYEEVARKLVI | 121 | P67936 | |
| ILYELKVELEETVVR | 316 | Q7Z404 | |
| KEIIAEYDTQVKEIR | 11 | O75044 | |
| ERDEYITKVSEEVTR | 201 | Q9C019 | |
| EEYIEEKKRVDICRE | 256 | Q9NQ25 | |
| YEPIVTTTKRKEEER | 1721 | Q9UI33 | |
| EYEEVKLVRDRVKEE | 281 | Q8IY18 | |
| DVKKVEEVVYDLSIR | 201 | Q15631 | |
| KTIRVKIVDEEEYER | 596 | P57103 | |
| REDIYKRNIELKVEV | 41 | Q5VU43 | |
| KSRERETEELYQVIE | 291 | Q5VU43 |